Autonomix advances toward U.S. clinical trials in 2025
Medical has completed the integration and design enhancements of the Apex 6 Generator into a fully integrated transvascular ...
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...